Contents lists available at ScienceDirect

Infection, Genetics and Evolution

journal homepage: www.elsevier.com/locate/meegid

Short communication

Genetic diversity and evolution of SARS-CoV-2 Tung Phan⁎

Division of Clinical Microbiology, University of Pittsburgh and University of Pittsburgh Medical Center, Pittsburgh, PA, USA

A R T I C L E I N F O

Keywords: Coronavirus SARS-CoV-2 Mutations Genomic diversity

A B S T R A C T

COVID-19 is a viral respiratory illness caused by a new coronavirus called SARS-CoV-2. The World Health Organization declared the SARS-CoV-2 outbreak a global public health emergency. We performed genetic analyses of eighty-six complete or near-complete genomes of SARS-CoV-2 and revealed many mutations and deletions on coding and non-coding regions. These observations provided evidence of the genetic diversity and rapid evolution of this novel coronavirus.

1. The study

A new coronavirus SARS-CoV-2 is spreading cross the world (Phan, 2020). Since the virus emerged at the seafood wholesale market at the end of last year (Zhu et al., 2019), the number of infected cases has been rising dramatically (Velavan and Meyer, 2020). Human-to-human transmission of SARS-CoV-2 has been confirmed (Nishiura et al., 2020). The virus has been detected in bronchoalveolar-lavage (Zhu et al., 2019), sputum (Lin et al., 2020), saliva (K.K. To et al., 2020), throat (Bastola et al., 2020) and nasopharyngeal swabs (To et al., 2020).

Nucleotide substitution has been proposed to be one of the most important mechanisms of viral evolution in nature (Lauring and Andino, 2010). The rapid spread of SARS-CoV-2 raises intriguing questions such as whether its evolution is driven by mutations. To as- sess the genetic variation, eighty-six complete or near-complete gen- omes of SARS-CoV-2 were collected from GISAID [https://www.gisaid. org/]. These SARS-CoV-2 strains were detected in infected patients from China (50), USA (11), Australia (5), Japan (5), France (4), Sin- gapore (3), England (2), Taiwan (2), South Korea (1), Belgium (1), Germany (1), and Vietnam (1). The pair-wise nucleotide sequence alignment was performed by ClustalX2 (Saitou and Nei, 1987), and the sequence of the strain China/WHU01/2020/EPI_ISL_406716 was used as a reference genome.

Like other betacoronaviruses, the genome of SARS-CoV-2 has a long ORF1ab polyprotein at the 5′ end, followed by four major structural

proteins, including the spike surface glycoprotein, small envelope protein, matrix protein, and nucleocapsid protein (Phan, 2020). Our genetic analysis discovered three deletions in the genomes of SARS- CoV-2 from Japan (Aichi), USA (Wisconsin), and Australia (Victoria) as shown in Fig. 1. Two deletions (three nucleotides and twenty-four nu- cleotides) were in the ORF1ab polyprotein, and one deletion (ten nu- cleotides) was in the 3′ end of the genome.

It is interesting that our nucleotide sequence alignment also re- vealed ninety-three mutations over the entire genomes of SARS-CoV-2 (Table 1). Forty-two missense mutations were identified in all the major non-structural and structural proteins, except the envelope protein. Twenty-nine missense mutations were in the ORF1ab polyprotein, eight in the spike surface glycoprotein, one in the matrix protein, and four in the nucleocapsid protein. Of note, three mutations (D354, Y364, and F367) located in the spike surface glycoprotein receptor-binding do- main. The spike surface glycoprotein plays an essential role in binding to receptors on the host cell and determines host tropism (Fung and Liu, 2019). It is also the major target of neutralizing antibodies (Yu et al., 2020). Mutations in the spike surface glycoprotein might induce its conformational changes, which probably led to the changing anti- genicity. To date, a study on localization of amino acids involved in conformational changes of the SARS-CoV-2 spike surface glycoprotein structure is not available. The identification of these amino acids is of significance and should be investigated by further studies.

https://doi.org/10.1016/j.meegid.2020.104260 Received 17 February 2020; Accepted 20 February 2020

⁎ Corresponding author. E-mail address: [email protected].

Infection, Genetics and Evolution 81 (2020) 104260

Available online 21 February 2020 1567-1348/ © 2020 Elsevier B.V. All rights reserved.

T

Fig. 1. Genomic organization of SARS-CoV-2 and pairwise nucleotide sequence alignment showing deletions in the ORF1ab polyprotein and in the 3′ end of the genome.

Table 1 Mutations found in the entire genome of SARS-CoV-2 strains. The number in the parentheses indicated the location of amino acid in its protein.

Genomic region No. nt mutations Missense mutation SARV-CoV-2 strain

5′ UTR 8 N/A ORF1ab polyprotein 48 29

A (117) → T USA/CA3/2020/EPI_ISL_408008 USA/CA4/2020/EPI_ISL_408009

P (309) → S France/IDF0515/2020/EPI ISL_408430 S (428) → N USA/CA1/2020/EPI_ISL_406034 T (609) → I USA/CA5/2020/EPI_ISL_408010 A (1176) → V Japan/TY-WK-012/2020/EPI_ISL_408665 L (1599) → F Korea/KCDC03/2020/EPI_ISL_407193 I (1607) → V USA/CA3/2020/EPI_ISL_408008

USA/CA4/2020/EPI_ISL_408009 M (2194) → T Shenzhen/SZTH-004/2020/EPI_ISL_406595 L (2235) → I Wuhan/WH01/2019/EPI_ISL_406798 I (2244) → T Wuhan/IPBCAMS-WH-03/2019/EPI_ISL_403930 G (2251) → S Wuhan/WIV05/2019/EPI_ISL_402128 A (2345) → V Shandong/IVDC-SD-001/2020/EPI_ISL_408482 G (2534) → V Wuhan/IPBCAMS-WH-05/2020/EPI_ISL_403928 D (2579) → A Wuhan/WIV07/2019/EPI_ISL_402130 N (2708) → S Wuhan/IPBCAMS-WH-01/2019/EPI_ISL_402123 F (2908) → I Wuhan/IPBCAMS-WH-01/2019/EPI_ISL_402123 T (3058) → I France/IDF0515/2020/EPI_ISL_408430 S (3099) → L Shenzhen/HKU-SZ-005/2020/EPI_ISL_405839 L (3606) → F Yunnan/IVDC-YN-003/2020/EPI_ISL_408480

Shandong/IVDC-SD-001/2020/EPI_ISL_408482 Chongqing/IVDC-CQ-001/2020/EPI_ISL_408481 Singapore/3/2020/EPI_ISL_407988 France/IDF0515/2020/EPI_ISL_408430 USA/AZ1/2020/EPI_ISL_406223

E (3764) → D Japan/KY-V-029/2020/EPI_ISL_408669 N (3833) → K Wuhan/WH01/2019/EPI_ISL_406798 W (5308) → C Taiwan/2/2020/EPI_ISL_406031 T (5579) → I USA/CA2/2020/EPI_ISL_406036 I (6075) → T England/02/2020/EPI_ISL_407073

England/01/2020/EPI_ISL_407071 P (6083) → L Japan/AI/I-004/2020/EPI_ISL_407084 F (6309) → Y Sichuan/IVDC-SC-001/2020/EPI_ISL_408484 E (6565) → D Shenzhen/SZTH-004/2020/EPI_ISL_406595 K (6958) → R Wuhan/WIV05/2019/EPI_ISL_402128 D (7018) → N Wuhan/WIV02/2019/EPI_ISL_402127

(continued on next page)

T. Phan Infection, Genetics and Evolution 81 (2020) 104260

2

Acknowledgement

We acknowledge support from Division of Clinical Microbiology, University of Pittsburgh Medical Center.

Declaration of Competing Interest

The author declares no competing financial interests.

References

Bastola, A., Sah, R., Rodriguez-Morales, A.J., Lal, B.K., Jha, R., Ojha, H.C., Shrestha, B., Chu, D.K.W., Poon, L.L.M., Costello, A., Morita, K., Pandey, B.D., 2020. The first 2019 novel coronavirus case in Nepal. Lancet Infect. Dis (pii: S1473-3099(20)300670), (in press), [Epub ahead of print].

Fung, T.S., Liu, D.X., 2019. Human coronavirus: host-pathogen interaction. Annu. Rev. Microbiol. 73, 529–557.

K.K. To, Tsang, O.T., Chik-Yan, C.Y., Chan, K.H., Wu, T.C., Chan, J.M.C., Leung, W.S., Chik, T.S., Choi, C.Y., Kandamby, D.H., Lung, D.C., Tam, A.R., Poon, R.W., Fung, A.Y., Hung, I.F., Cheng, V.C., Chan, J.F., Yuen, K.Y., 2020. Consistent detection of 2019 novel coronavirus in saliva. Clin. Infect. Dis. https://doi.org/10.1093/cid/

ciaa149. (pii: ciaa149). Lauring, A.S., Andino, R., 2010. Quasispecies theory and the behavior of RNA viruses.

PLoS Pathog. 6, e1001005. https://doi.org/10.1371/journal.ppat.1001005. Lin, X., Gong, Z., Xiao, Z., Xiong, J., Fan, B., Liu, J., 2020. Novel coronavirus pneumonia

outbreak in 2019: Computed tomographic findings in two cases. Korean J. Radiol. https://doi.org/10.3348/kjr.2020.0078.

Nishiura, H., Linton, N.M., Akhmetzhanov, A.R., 2020. Initial cluster of novel coronavirus (2019-nCoV) infections in Wuhan, China is consistent with substantial human-to- human transmission. J. Clin. Med. 9https://doi.org/10.3390/jcm9020488. pii: E488.

Phan, T., 2020. Novel coronavirus: from discovery to clinical diagnostics. Infect. Genet. Evol. 79, 104211.

Saitou, N., Nei, M., 1987. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4, 406–425.

Velavan, T.P., Meyer, C.G., 2020. The Covid-19 epidemic. Tropical Med. Int. Health. https://doi.org/10.1111/tmi.13383.

Yu, F., Du, L., Ojcius, D.M., Pan, C., Jiang, S., 2020. Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China. Microbes Infect. https://doi.org/10.1016/j.micinf.2020.01.003. pii: S1286-4579(20)300253.

Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., Niu, P., Zhan, F., Ma, X., Wang, D., Xu, W., Wu, G., Gao, G.F., Tan, W., Investigating, China Novel Coronavirus, 2019. Research Team. A novel coronavirus from patients with pneumonia in China. N. Engl. J. Med. 2020. https://doi.org/10. 1056/NEJMoa2001017.

Table 1 (continued)

Genomic region No. nt mutations Missense mutation SARV-CoV-2 strain

Spike polyprotein 14 8 F (32) → I Wuhan/HBCDC-HB-01/2019/EPI_ISL_402132 H (49) → Y Guangdong/20SF174/2020/EPI_ISL_406531

Guangdong/20SF040/2020/EPI_ISL_403937 Guangdong/20SF028/2020/EPI_ISL_403936

S (247) → R Australia/VIC01/2020/EPI_ISL_406844 N (354) → D Shenzhen/SZTH-004/2020/EPI_ISL_406595 D (364) → Y Shenzhen/SZTH-004/2020/EPI_ISL_406595 V (367) → F France/IDF0372/2020/EPI_ISL_406596

France/IDF0373/2020/EPI_ISL_406597 D (614) → G Germany/BavPat1/2020/EPI_ISL_406862 P (1143) → L Australia/QLD02/2020/EPI_ISL_407896

Intergenic region 5 N/A Envelope protein 0 0 Matrix protein 2 1

D (209) → H Singapore/2/2020/EPI_ISL_407987 Intergenic region 6 N/A Nucleocapsid protein 7 4

T (148) → I Shenzhen/SZTH-004/2020/EPI_ISL_406595 S (194) → L Shenzhen/SZTH-003/2020/EPI_ISL_406594

Foshan/20SF207/2020/EPI_ISL_406534 USA/CA3/2020/EPI_ISL_408008 USA/CA4/2020/EPI_ISL_408009

S (202) → N Australia/QLD02/2020/EPI_ISL_407896 P (344) → S Guangzhou/20SF206/2020/EPI_ISL_406533

3′UTR 3 N/A Complete genome 93 42

T. Phan Infection, Genetics and Evolution 81 (2020) 104260

3

  • Genetic diversity and evolution of SARS-CoV-2
    • The study
    • Acknowledgement
    • mk:H1_4
    • mk:H1_5
    • References

[INSERT TITLE HERE] 1

Running head: [INSERT TITLE HERE]

[INSERT TITLE HERE]

Student Name

Allied American University

Author Note

This paper was prepared for [INSERT COURSE NAME], [INSERT COURSE ASSIGNMENT] taught by [INSERT INSTRUCTOR’S NAME].

Directions: Write a response that is at least one page in length for each of the following questions.

1. Describe conditional release and explain the concept of good time.

2. Explain the role of parole boards. What is their overall purpose? Provide one example of a state parole board and outline its structure.

3. Describe victim participation and the influence of the victim impact statement.

4. What is the primary responsibility of institutional parole staff? Do you believe that this is an important and/or beneficial task? Why or why not?

5. Compare and contrast executive clemency, reprieve, commutation, and pardon.

[INSERT TITLE HERE] 1

Running head: [INSERT TITLE HERE]

[INSERT TITLE HERE]

Student Name

Allied American University

Author Note

This paper was prepared for [INSERT COURSE NAME], [INSERT COURSE ASSIGNMENT] taught by [INSERT INSTRUCTOR’S NAME].

Directions: Respond to the following questions using complete sentences. Your answer should be at least 1 paragraph in length, which must be composed of three to five sentences.

1. What are the three basic services provided by a parole agency?

2. How does the independent model of parole administration differ from the consolidated model?

3. What are the advantages and disadvantages of the independent model as opposed to the consolidated model for administering parole?

4. What is the difference between parole and conditional release?

5. How do "truth-in-sentencing" statutes affect good time release?

6. How are parole board guidelines used to make a release decision? How do parole board guidelines take into account both classical and positivist views?

7. How do parole guidelines incorporate both the medical model and the concept of just deserts?

8. What has the Supreme Court ruled with respect to inmates being represented by attorneys at a parole release hearing?

9. What are the responsibilities of an institutional parole officer?

10. What are the various forms of executive clemency and what are the conditions under which they are granted?

Get help from top-rated tutors in any subject.

Efficiently complete your homework and academic assignments by getting help from the experts at homeworkarchive.com